1. Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation. (November 2017) Authors: Santoni-Rugiu, Eric; Grauslund, Morten; Melchior, Linea C.; Costa, Junia C.; Sørensen, Jens B.; Urbanska, Edyta M. Journal: Lung cancer Issue: Volume 113(2017) Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Molecular pathways and diagnosis in malignant mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group. (January 2019) Authors: Chapel, David B.; Churg, Andrew; Santoni-Rugiu, Eric; Tsujimura, Tohru; Hiroshima, Kenzo; Husain, Aliya N. Journal: Lung cancer Issue: Volume 127(2019) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗